The ability to introduce novel antimicrobial proteins into the phagolysosomes of granulocytes or macrophages may have important therapeutic implications but is currently limited by our rudimentary understanding of posttranslational processing and targeting of proteins destined for phagolysosomes. Because of their abundance and small size, neutrophil defensins present a compelling model for the exploration of posttranslational processing of granule proteins and their packaging into granules. Pulse-chase labelling, subcellular fractionation, and ultrastructural immunolocalization studies will be undertaken to determine the subcellular location of the proteolytic processing steps of human defensin precursors in HL-60 cell line and human bone marrow cells. We will characterize the endopeptidases that are responsible for defensin maturation. We will ascertain whether defensin precursors undergo posttranslational modification and whether proteoglycans play an obligatory role in defensin processing and packaging. We will search for specific carrier proteins involved in the intracellular sorting of defensins to azurophil granules. We will express a small exogenous (rabbit) defensin cDNA in HL-60 cells, and by PCR mutagenesis explore the structural requirements for the correct processing and packaging of defensin protein. We will use retroviral vectors to express exogenous defensins in phagocytic cell lines and then evaluate their posttranslational processing, subcellular targeting and effects of defensins on the microbicidal activity of the modified phagocytes. Overall, the studies will shed light on basic mechanisms of synthesis and subcellular trafficking of the major polypeptide constituent of azurophil granules. In the longer term, these studies may lead to therapeutic strategies for targeting exogenous microbicidal proteins into the cytoplasmic granules of human or animal neutrophils, monocytes and macrophages.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL046809-02
Application #
2223220
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1993-01-01
Project End
1996-12-31
Budget Start
1994-01-01
Budget End
1994-12-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Ganz, Tomas (2007) Molecular control of iron transport. J Am Soc Nephrol 18:394-400
Linzmeier, Rose M; Ganz, Tomas (2006) Copy number polymorphisms are not a common feature of innate immune genes. Genomics 88:122-6
Sorensen, Ole E; Thapa, Dharma R; Roupe, K Markus et al. (2006) Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest 116:1878-85
Wehkamp, Jan; Salzman, Nita H; Porter, Edith et al. (2005) Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 102:18129-34
Miller, Lloyd S; Sorensen, Ole E; Liu, Philip T et al. (2005) TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J Immunol 174:6137-43
Sorensen, Ole E; Thapa, Dharma R; Rosenthal, Adam et al. (2005) Differential regulation of beta-defensin expression in human skin by microbial stimuli. J Immunol 174:4870-9
Linzmeier, Rose M; Ganz, Tomas (2005) Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics 86:423-30
Ganz, Tomas (2004) Hepcidin in iron metabolism. Curr Opin Hematol 11:251-4
Hertz, Cheryl J; Wu, Qi; Porter, Edith Martin et al. (2003) Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol 171:6820-6
Ganz, Tomas (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783-8

Showing the most recent 10 out of 43 publications